ORIGINAL RESEARCH article
Front. Nutr.
Sec. Clinical Nutrition
Volume 12 - 2025 | doi: 10.3389/fnut.2025.1655272
Impact of zinc deficiency on mortality risk in patients with chronic obstructive pulmonary disease: A retrospective Analysis
Provisionally accepted
- 1Chi Mei Medical Center, Tainan, Taiwan
- 2E-Da Hospital, Yanchao District, Taiwan
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Although nutritional deficiencies are increasingly recognized as modifiable factors in COPD progression, the relationship between zinc status and clinical outcomes remains poorly understood. This study examined the association between zinc deficiency and clinical outcomes in patients with COPD. Methods: We conducted a retrospective cohort study using the TriNetX Research Network to analyze patients aged ≥18 years with established COPD, who underwent zinc testing between January 2010 and June 2023. Patients were categorized into zinc deficiency (serum zinc <70 μg/dL) and control groups (70-120 μg/dL). Using 1:1 propensity score matching, we created balanced cohorts controlling for demographics, comorbidities, and medications. The primary outcome was 6-month mortality, whereas secondary outcomes included COPD exacerbations, pneumonia, intensive care unit (ICU) admissions, hospital admissions, and hyperglycemic episodes. We also analyzed the impact of severe zinc deficiency (<50 μg/dL) and high zinc levels (>120 μg/dL) on prognosis. Results: After matching, 3,525 patients were included in each group. Zinc deficiency was associated with a significantly increased 6-month mortality risk (hazard ratio [HR]: 1.94, 95% confidence interval [CI]: 1.49-2.52, p<0.001). The secondary outcomes demonstrated consistent patterns of increased morbidity, including higher risks of pneumonia (HR 1.24; p = 0.031), hyperglycemia (HR 1.28; p < 0.001), ICU admission (HR 1.61; p < 0.001), and hospital admission (HR 1.28; p < 0.001), with no significant difference in the risk of COPD exacerbations. Severe zinc deficiency exhibited dose-dependent effects, with markedly elevated risks across all outcomes. Interestingly, high zinc levels were also associated with increased mortality (HR, 1.74; p = 0.005), suggesting a U-shaped relationship between zinc status and mortality risk. Conclusion: Zinc deficiency represents a significant and independent risk factor for mortality and morbidity in patients with COPD, with evidence of dose-dependent effects and a U-shaped risk relationship. These findings suggest that assessing and optimizing zinc status may represent an important yet under-recognized component of comprehensive COPD management strategies.
Keywords: zinc deficiency, chronic obstructive pulmonary disease, Mortality, prognosis, Pneumonia
Received: 27 Jun 2025; Accepted: 29 Sep 2025.
Copyright: © 2025 Chen, Yu, Lai, Liu, Chang, Wu and Hung. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Kuo-Chuan Hung, ed102605@gmail.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.